Table 5.
Level of social anxiety, state anxiety (X-1) or trait anxiety (X-2) and self-perceived health status, fear of health deterioration after starting work with coronavirus patients, having had a coronavirus infection, having received coronavirus vaccination and fear of contracting the disease while working with coronavirus patients.
| Liebowitz social anxiety | State-trait anxiety inventory | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| scale | |||||||||
| STAI X-1 | STAI X-2 | ||||||||
| Mean | Min. | Max. | Mean | Min. | Max. | Mean | Min. | Max. | |
| Self-assessment of one's health status | |||||||||
| Very good | 58.8 ± 33.2 | 0 | 105 | 49.9 ± 2.2 | 44 | 55 | 48.9 ± 2.9 | 42 | 56 |
| Well | 51.8 ± 31.7 | 0 | 144 | 50.0 ± 1.9 | 44 | 56 | 49.3 ± 2.5 | 41 | 59 |
| Moderate | 50.2 ± 27.9 | 5 | 126 | 50.2 ± 1.7 | 46 | 55 | 48.9 ± 2.9 | 43 | 55 |
| Poor | 41.8 ± 30.9 | 4 | 68 | 49.5 ± 2.6 | 46 | 52 | 50.5 ± 0.6 | 50 | 51 |
| I do not know | 6.0 ± 0 | 6 | 6 | 50.0 ± 0 | 50 | 50 | 43.0 ± 0 | 43 | 43 |
| ρ-value | 0.132 | NS | NS | ||||||
| P-value | <0.05 | ||||||||
| Fear of deterioration of the health status after starting work with coronavirus patients | |||||||||
| Yes | 63.2 ± 26.3 | 0 | 108 | 49.6 ± 2.0 | 44 | 55 | 49.0 ± 3.0 | 41 | 59 |
| No | 43.5 ± 34.2 | 0 | 144 | 50.4 ± 1.8 | 45 | 56 | 49.3 ± 2.5 | 42 | 56 |
| I do not know | 50.9 ± 27.0 | 0 | 97 | 50.3 ± 1.9 | 47 | 56 | 48.8 ± 2.6 | 43 | 54 |
| ρ-value | 0.251 | 0.185 | NS | ||||||
| P-value | <0.001 | <0.01 | |||||||
| Previous coronavirus infection | |||||||||
| Yes | 59.3 ± 29.2 | 0 | 108 | 49.8 ± 2.0 | 44 | 56 | 48.8 ± 2.8 | 41 | 48 |
| No | 46.9 ± 32.8 | 0 | 144 | 50.1 ± 1.9 | 45 | 55 | 49.6 ± 2.5 | 43 | 59 |
| I do not remember | 44.7 ± 32.1 | 0 | 106 | 50.5 ± 1.5 | 48 | 56 | 48.9 ± 2.8 | 42 | 55 |
| ρ-value | 0.219 | 0.130 | NS | ||||||
| P-value | <0.001 | <0.05 | |||||||
| Vaccination against coronavirus | |||||||||
| No | 41.1 ± 35.7 | 0 | 126 | 50.0 ± 2.0 | 46 | 54 | 49.5 ± 3.1 | 43 | 55 |
| Two doses | 52.2 ± 31.1 | 0 | 144 | 50.0 ± 2.0 | 44 | 56 | 49.2 ± 2.6 | 42 | 59 |
| One dose | 56.2 ± 29.0 | 3 | 108 | 50.1 ± 1.5 | 46 | 54 | 48.3 ± 3.0 | 41 | 56 |
| Single-dose vaccine | 58.9 ± 32.7 | 0 | 108 | 49.9 ± 2.0 | 44 | 55 | 49.3 ± 2.7 | 43 | 55 |
| ρ-value P-value |
NS | NS | NS | ||||||
| Fear of contracting the disease while working with coronavirus patients | |||||||||
| I am not afraid | 31.6 ± 29.5 | 0 | 126 | 50.6 ± 2.0 | 45 | 56 | 49.5 ± 2.1 | 44 | 55 |
| Yes, to a lesser degree than with other diseases | 50.0 ± 19.8 | 36 | 64 | 51.0 ± 1.4 | 50 | 52 | 52.5 ± 3.5 | 50 | 55 |
| Yes, to the same degree as with other diseases | 57.1 ± 30.6 | 0 | 144 | 50.0 ± 1.6 | 44 | 56 | 48.9 ± 2.7 | 41 | 56 |
| Yes, to a higher degree than with other diseases | 65.6 ± 25.4 | 9 | 108 | 49.5 ± 2.2 | 44 | 45 | 49.1 ± 3.0 | 43 | 59 |
| I do not know | 34.4 ± 28.9 | 0 | 60 | 50.2 ± 2.5 | 43 | 52 | 48.2 ± 3.3 | 43 | 52 |
| ρ-value P-value |
NS | NS | NS | ||||||
Spearman's Rank Correlation Test, ρ = Spearman's rank correlation coefficient, NS- not significant.